N/A Completed N=40 Randomized Double-blind Supportive Care

Use of Interferential Current (IFC) Therapy After Total Knee Arthroplasty

Osteo Arthritis Knee

Source: ClinicalTrials.gov NCT04137731 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Sep 2023

Primary outcomePrimary: Post-operative Opioid Pain Medication Usage — 24.5; 15.0 MME

Summary

Interferential Current Therapy (IFC) is a form of electrical therapy that utilizes two simultaneous low frequency electrical stimulation which when they cross interfere with one another resulting in an interference or beat frequency. This beat frequency provides a therapeutic area of relief by blocking painful stimuli at the area of interest. IFC is different from the other electrical treatment modalities used because the cancellation effect allows for establishment of the treatment area to be in the deeper tissues of the body, whereas other electrical modalities can only be used to treat superficial body parts that lie just under the skin. The main objective of this proposed study is to assess the post-operative short term outcomes of the patients who receive IFC treatment during their post-total knee arthroplasty (TKA) surgery hospital stay. The implications of the study would be improved patient outcome which could result in shorter hospital stay, reduced use of opioid medication, decreased need for manipulation under anesthesia and reduced re-admission rate.

Outcome Measures

Outcome	Result	p-value
PRIMARY Post-operative Opioid Pain Medication Usage	60.0; 60.0	—
PRIMARY Visual Pain Score (VAS)	6; 6	—
PRIMARY Visual Pain Score	5.5; 6	—

Eligibility Criteria

Inclusion Criteria:Adult patients with knee osteoarthritis who have failed conservative therapy and undergoing elected TKA.

Exclusion Criteria

i. <18 years old ii. Any patient with pacemaker or any electrical stimulator device iii. Patients without capacity to consent for the study iv. Patients not able to have local nerve block or spinal anesthesia v. Patients with prior chronic opioid use vi. Patients who are categorized to have 'Severe' fear and anxiety responses to pain, according to the Pain catastrophizing scale (PCS) survey.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04137731). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.